As of 29 Oct 2024, Alnylam Pharmaceuticals total assets is $3.83B, an increase of 7.99% to 2022. This figure includes all the resources and properties owned by Alnylam Pharmaceuticals, reflecting its financial standing at that time.
Year | Total Assets | Change |
---|---|---|
2023 | $3.83B | 7.99% |
2022 | $3.55B | -2.66% |
2021 | $3.64B | 6.93% |
2020 | $3.41B | 42.25% |
2019 | $2.40B | 52.09% |
2018 | $1.57B | - |